• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健中治疗的痴呆患者的死亡率和机构化:神经精神症状的影响(NeDEM项目)

Mortality and institutionalization of patients with dementia treated in primary care: influence of neuropsychiatric symptoms (NeDEM project).

作者信息

García-Martín Victoria, de Hoyos-Alonso MCanto, Martín-Fernández Jesús, Del Cura-González Isabel

机构信息

Epidemiology and Public Health at Universidad Rey Juan Carlos (Rey Juan Carlos University), Madrid, Spain.

Preventive Medicine and Public Health Service, Infanta Leonor-Virgen de La Torre University Hospital, Madrid, Spain.

出版信息

BMC Geriatr. 2025 Sep 24;25(1):701. doi: 10.1186/s12877-025-06339-0.

DOI:10.1186/s12877-025-06339-0
PMID:40993548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12462034/
Abstract

BACKGROUND

Neuropsychiatric symptoms (NPSs) are common in people with dementia (PWD), but their associations with the risk of institutionalization and mortality are controversial. The objective of this study was to estimate the incidence of institutionalization and death among PWD treated in primary care (PC) and to analyse the associations between NPSs and these events.

METHODS

This was a longitudinal analytical observational study of PWD in PC with a 4-year follow-up. Data on sociodemographic, clinical and functional characteristics and prescribed treatments for dementia were collected. NPSs were examined with the Neuropsychiatric Inventory (NPI) scale and according to the presence of clinically relevant neuropsychiatric subsyndromes. The incidence of institutionalization and cumulative mortality were calculated annually and at four years. Survival analysis with Kaplan‒Meier curves and Cox regression was performed to analyse the influence of NPSs on institutionalization and mortality.

RESULTS

A total of 124 patients with a mean age of 82.5 (8.0) years were included, and 69.4% were women. At four years, the institutionalization rate in a nursing home was 29.8% (95% CI 22.0; 38.7), with a median time to institutionalization of 13.2 months (IQR: 6.8-31.5). The mortality rate was 48.4% (95% CI 39.3; 57.5), with a median survival time of 21.7 months (IQR: 14.2-32.0). The NPI score was associated with institutionalization (HR 1.27, 95% CI 1.12, 1.45) and mortality (HR 1.47, 95% CI 1.40, 1.54). Among the subsyndromes, the presence of clinically relevant apathy was associated with institutionalization (HR 2.23, 95% CI 1.29, 3.88) and mortality (HR 1.56, 95% CI 1.34, 1.81).

CONCLUSIONS

In PWD who were followed up in the community for four years, one-third of the patients were institutionalized, and half died. The intensity of the NPSs influences both institutionalization and mortality, with subsyndrome apathy (formed by the symptoms of apathy and appetite alterations) being the one that most influences both outcomes.

摘要

背景

神经精神症状(NPSs)在痴呆症患者(PWD)中很常见,但其与机构收容风险和死亡率之间的关联存在争议。本研究的目的是估计在初级保健(PC)中接受治疗的PWD的机构收容率和死亡率,并分析NPSs与这些事件之间的关联。

方法

这是一项对PC中的PWD进行的纵向分析观察性研究,随访4年。收集了社会人口统计学、临床和功能特征以及痴呆症规定治疗的数据。使用神经精神量表(NPI)并根据临床相关神经精神亚综合征的存在情况对NPSs进行检查。每年和四年计算机构收容率和累积死亡率。采用Kaplan-Meier曲线和Cox回归进行生存分析,以分析NPSs对机构收容和死亡率的影响。

结果

共纳入124例患者,平均年龄82.5(8.0)岁,69.4%为女性。四年时,养老院的机构收容率为29.8%(95%CI 22.0;38.7),机构收容的中位时间为13.2个月(IQR:6.8 - 31.5)。死亡率为48.4%(95%CI 39.3;57.5),中位生存时间为21.7个月(IQR:14.2 - 32.0)。NPI评分与机构收容(HR 1.27,95%CI 1.12,1.45)和死亡率(HR 1.47,95%CI 1.40,1.54)相关。在亚综合征中,临床相关的冷漠症状与机构收容(HR 2.23,95%CI 1.29,3.88)和死亡率(HR 1.56,95%CI 1.34,1.81)相关。

结论

在社区随访四年的PWD中,三分之一的患者被机构收容,一半患者死亡。NPSs的严重程度影响机构收容和死亡率,其中由冷漠和食欲改变症状组成的亚综合征冷漠对这两个结局的影响最大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/357d4091e88e/12877_2025_6339_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/265b6cd59f15/12877_2025_6339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/edce776198de/12877_2025_6339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/912da5690d84/12877_2025_6339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/903ee33e81bd/12877_2025_6339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/29430979b7a2/12877_2025_6339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/cb9a4da5bdb9/12877_2025_6339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/357d4091e88e/12877_2025_6339_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/265b6cd59f15/12877_2025_6339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/edce776198de/12877_2025_6339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/912da5690d84/12877_2025_6339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/903ee33e81bd/12877_2025_6339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/29430979b7a2/12877_2025_6339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/cb9a4da5bdb9/12877_2025_6339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d03/12462034/357d4091e88e/12877_2025_6339_Fig7_HTML.jpg

相似文献

1
Mortality and institutionalization of patients with dementia treated in primary care: influence of neuropsychiatric symptoms (NeDEM project).初级保健中治疗的痴呆患者的死亡率和机构化:神经精神症状的影响(NeDEM项目)
BMC Geriatr. 2025 Sep 24;25(1):701. doi: 10.1186/s12877-025-06339-0.
2
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.痴呆症老年人行为和心理症状的慢性抗精神病药物撤药与继续用药对比
Cochrane Database Syst Rev. 2013 Mar 28(3):CD007726. doi: 10.1002/14651858.CD007726.pub2.
3
A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.对感官、心理和行为干预措施在管理老年痴呆症患者激越方面的临床有效性和成本效益的系统评价。
Health Technol Assess. 2014 Jun;18(39):1-226, v-vi. doi: 10.3310/hta18390.
4
Vesicoureteral Reflux膀胱输尿管反流
5
Algorithm-based pain management for people with dementia in nursing homes.基于算法的养老院痴呆患者疼痛管理。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013339. doi: 10.1002/14651858.CD013339.pub2.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
8
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
9
Palliative Care Program for Community-Dwelling Individuals With Dementia and Caregivers: The IN-PEACE Randomized Clinical Trial.针对社区痴呆患者及其照料者的姑息治疗项目:IN-PEACE随机临床试验
JAMA. 2025 Mar 18;333(11):962-971. doi: 10.1001/jama.2024.25845.
10
Case management approaches to home support for people with dementia.针对痴呆症患者居家支持的个案管理方法。
Cochrane Database Syst Rev. 2015 Jan 5;1(1):CD008345. doi: 10.1002/14651858.CD008345.pub2.

本文引用的文献

1
Trend analysis and future predictions of global burden of alzheimer's disease and other dementias: a study based on the global burden of disease database from 1990 to 2021.阿尔茨海默病及其他痴呆症全球负担的趋势分析与未来预测:一项基于1990年至2021年全球疾病负担数据库的研究
BMC Med. 2025 Jul 1;23(1):378. doi: 10.1186/s12916-025-04169-w.
2
Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer's Disease.了解神经精神症状在阿尔茨海默病功能衰退中的作用。
J Neuropsychiatry Clin Neurosci. 2025 Jun 26:appineuropsych20250015. doi: 10.1176/appi.neuropsych.20250015.
3
Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study.
2015 - 2021年美国医疗保险受益人中痴呆症的发病率和患病率:基于人群的研究
BMJ. 2025 May 20;389:e083034. doi: 10.1136/bmj-2024-083034.
4
The protective effect of vitamin B12 on neuropsychiatric symptoms in dementia-free older adults in a multi-ethnic population.维生素B12对多民族人群中无痴呆症老年人神经精神症状的保护作用。
Clin Nutr. 2025 Jan;44:25-32. doi: 10.1016/j.clnu.2024.11.037. Epub 2024 Nov 24.
5
Burden in caregivers of primary care patients with dementia: influence of neuropsychiatric symptoms according to disease stage (NeDEM project).痴呆初级保健患者照护者的负担:根据疾病阶段的神经精神症状的影响(NeDEM 项目)。
BMC Geriatr. 2023 Aug 29;23(1):525. doi: 10.1186/s12877-023-04234-0.
6
The Costs of Dementia in Europe: An Updated Review and Meta-analysis.欧洲的痴呆症成本:一项更新的综述和荟萃分析。
Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15.
7
Predictors of nursing home placement at 2 years in Alzheimer's disease: A follow-up survey from the THERAD study.阿尔茨海默病患者两年内入住养老院的预测因素:THERAD研究的随访调查
Int J Geriatr Psychiatry. 2022 Jun;37(6). doi: 10.1002/gps.5724.
8
Prediction of Institutionalization for Patients With Dementia in Taiwan According to Condition at Entry to Dementia Collaborative Care.根据进入痴呆症协作护理时的状况预测台湾痴呆症患者的机构化。
J Appl Gerontol. 2022 May;41(5):1357-1364. doi: 10.1177/07334648211073129. Epub 2022 Feb 27.
9
Clinical Trajectories of Neuropsychiatric Symptoms in Mild-Moderate to Advanced Dementia.轻度-中度至晚期痴呆患者神经精神症状的临床轨迹。
J Alzheimers Dis. 2022;86(2):861-875. doi: 10.3233/JAD-215133.
10
Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.在初级保健随访中不同痴呆阶段患者的神经精神症状和亚综合征(NeDEM 项目):一项横断面研究。
BMC Geriatr. 2022 Jan 22;22(1):71. doi: 10.1186/s12877-022-02762-9.